Standout Papers

Frequent deletions and down-regulation of micro- RNA genes <i>miR15</i> and <i... 1997 2026 2006 2016 3.8k
  1. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia (2002)
    George A. Calin, Calin Dan Dumitru et al. Proceedings of the National Academy of Sciences
  2. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines (2008)
    Michael Hallek, Bruce D. Cheson et al. Blood
  3. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL (2018)
    Michael Hallek, Bruce D. Cheson et al. Blood
  4. Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy (1997)
    Sergio Giralt, Elihu H. Estey et al. Blood
  5. CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients (2011)
    Barbara Savoldo, Carlos A. Ramos et al. Journal of Clinical Investigation
  6. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. (1998)
    Issa F. Khouri, Michael J. Keating et al. Journal of Clinical Oncology
  7. Superoxide dismutase as a target for the selective killing of cancer cells (2000)
    Peng Huang, Feng Li et al. Nature
  8. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study (2002)
    Michael J. Keating, Ian W. Flinn et al. Blood
  9. Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia (2005)
    Michael J. Keating, Susan O’Brien et al. Journal of Clinical Oncology
  10. Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia (2005)
    Rui‐Hua Xu, Hélène Pelicano et al. Cancer Research
  11. ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia (2004)
    Laura Z. Rassenti, Lang Huynh et al. New England Journal of Medicine
  12. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. (1990)
    Bruce D. Cheson, Peter A. Cassileth et al. Journal of Clinical Oncology
  13. Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia (2000)
    Hagop M. Kantarjian, Susan O’Brien et al. Journal of Clinical Oncology
  14. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes (2000)
    Álvaro Aguayo, Hagop M. Kantarjian et al. Blood
  15. Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes (1987)
    Saroj Vadhan‐Raj, Michael J. Keating et al. New England Journal of Medicine
  16. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia (2008)
    Constantine S. Tam, Susan O’Brien et al. Blood
  17. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo (2011)
    Sabine Ponader, Shih-Shih Chen et al. Blood
  18. Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous Leukemia (1986)
    Moshe Talpaz, Hagop M. Kantarjian et al. New England Journal of Medicine
  19. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth (2016)
    Achinto Saha, Jinyun Liu et al. Nature Medicine
  20. Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia (2015)
    Philip A. Thompson, Constantine S. Tam et al. Blood

Immediate Impact

14 by Nobel laureates 32 from Science/Nature 235 standout
Sub-graph 1 of 16

Citing Papers

CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
Brown-fat-mediated tumour suppression by cold-altered global metabolism
2022 StandoutNature
21 intermediate papers

Works of Michael J. Keating being referenced

Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
2011
Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia
2005 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
Michael J. Keating 30311 20787 20959 21086 1.1k 65.3k
Hartmut Döhner 18626 11887 20674 17222 644 44.0k
Donna Neuberg 9201 11116 12077 14045 713 45.2k
Jörge E. Cortes 40429 9069 58990 23185 2.2k 82.8k
Francis J. Giles 15414 6100 20046 14728 778 41.0k
Brian Druker 21325 3870 29898 17055 597 54.0k
Michael Andreeff 10107 3475 15751 25506 987 47.2k
Moshe Talpaz 22419 4508 28654 10816 765 44.0k
Guillermo Garcia‐Manero 14343 3865 29771 17388 1.5k 42.9k
Clara D. Bloomfield 11828 5237 28029 17444 400 42.0k
Kenneth C. Anderson 7644 7313 41282 46654 1.4k 75.4k

All Works

Loading papers...

Rankless by CCL
2026